Soluble Urokinase Plasminogen Activator Receptor
- 1 January 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (1) , 18-23
Abstract
Background and Purpose—: Recent studies indicate that the urokinase system could have an important role in atherogenesis and plaque rupture. The relationships among the soluble urokinase plasminogen activator receptor (suPAR), carotid plaque, and incidence of ischemic stroke and coronary artery disease (CAD) events were studied in a prospective cohort. Methods—: Occurrence of carotid plaque and plasma levels of suPAR were assessed in 5166 men and women, aged 45 to 68 years, participating in the Malmö Diet and Cancer study. Incidences of ischemic stroke and CAD were monitored during a mean follow-up of 15 years. Results—: Subjects with carotid plaque had significantly higher levels of suPAR compared with those without carotid plaque. suPAR was associated with increased incidence of ischemic stroke (hazard ratio [HR] for third versus first tertile, 1.50; 95% confidence interval [CI], 1.06–2.11) and CAD (HR, 1.55; 95% CI, 1.13–2.13) after adjustment for risk factors. The risk factor–adjusted HR for ischemic stroke was 2.21 (95% CI, 1.52–3.22) in subjects with carotid plaque and high suPAR (ie, third tertile) and 1.51 (95% CI, 1.05–2.17) in subjects with carotid plaque and low suPAR compared with those without carotid plaque and low suPAR (reference). High levels of suPAR significantly increased the risk of ischemic stroke and CAD in subjects with carotid plaque. Conclusions—: suPAR is associated with increased occurrence of carotid plaque and increased incidence of ischemic stroke and CAD. Presence of both elevated levels of suPAR and carotid plaque increases the risk of ischemic stroke in an additive way.Keywords
This publication has 32 references indexed in Scilit:
- Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk ScoreInternational Journal of Cardiology, 2013
- Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic PlaqueStroke, 2012
- Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort studyCritical Care, 2011
- Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJournal of Internal Medicine, 2010
- Urokinase Receptor Is Necessary for Bacterial Defense against Pneumonia-Derived Septic Melioidosis by Facilitating PhagocytosisThe Journal of Immunology, 2010
- Participation of the urokinase receptor in neutrophil efferocytosisBlood, 2009
- Incident coronary events and case fatality in relation to common carotid intima‐media thicknessJournal of Internal Medicine, 2005
- Incidence of Stroke and Stroke Subtypes in Malmö, Sweden, 1990–2000Stroke, 2004
- Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesionsBlood Coagulation & Fibrinolysis, 2004
- The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesionJournal of Cell Science, 2004